Research Appraisalother

Deep learning-driven recognition of panoramic tumor microenvironment features in H&E sections and its application

Journal for immunotherapy of cancerZhang, Han, Huang, Qinyi, Shang, Bing et al.9 Apr 2026DOI

Clinical Snapshot

25CEBM
Evidence: Insufficientother

PICO Framework

P — PopulationNot applicable - this is a narrative review, not a systematic review with defined population criteria
I — InterventionDeep learning algorithms for analyzing H&E-stained tissue sections
C — ComparatorTraditional pathological diagnosis by manual microscopic examination
O — OutcomesRecognition and characterization of tumor microenvironment features, diagnostic accuracy, therapeutic response prediction

Bottom Line

This narrative review examines deep learning applications for analyzing tumor microenvironment features in H&E-stained tissue sections. While the technology shows promise for improving diagnostic accuracy and predicting therapeutic responses compared to traditional manual pathological examination, this review lacks the systematic methodology needed for evidence-based recommendations. The authors acknowledge current limitations in translating these computational tools to clinical practice. Without quantitative synthesis of diagnostic performance data, confidence intervals, or systematic quality assessment, clinicians cannot determine whether this technology is ready for routine implementation. The review serves as an overview of the field but does not provide sufficient evidence to change current pathological practice. Australian pathologists should await more rigorous systematic reviews and regulatory approval before considering adoption of these deep learning tools in routine diagnostic workflows.

Evidence: Insufficient

Key Findings

  • Effect Size: Not reported

  • Primary Outcome: Not applicable - narrative review without quantitative synthesis

  • Nnt Or Sensitivity: Not reported - review discusses diagnostic applications but provides no performance metrics

Clinical Application

Limited by current technology infrastructure, regulatory approval requirements, and need for specialized expertise Would require TGA approval for diagnostic applications, integration with existing pathology workflows, and consideration of Medicare Benefits Schedule coverage for computational pathology services Oncology patients requiring histopathological diagnosis, particularly those with complex tumor microenvironments

Abstract

The tumor microenvironment (TME), composed of tumor cells together with stromal cells, immune cells, vascular networks, and other components, constitutes a complex ecosystem that plays a decisive role in tumor initiation, progression, metastasis and therapeutic response. Traditional pathological diagnosis mainly relies on pathologists manually examining H&E-stained tissue sections under the microscope, a method that not only suffers from substantial interobserver variability but also has relatively low analytical efficiency. With the rapid development of computational pathology, the integration of whole-slide imaging technology and deep learning algorithms has provided powerful tools for characterizing tumor microenvironment. These techniques enable automated characterization of cellular, spatial and molecular heterogeneity within the tumor microenvironment, providing integrated insights that advance precision diagnostics and improve prediction of therapeutic response and patient outcomes. Based on a comprehensive review of existing research, this paper highlights recent advances in deep learning-driven recognition of panoramic TME features from H&E slides and their clinical applications and further discusses both the translational potential and current limitations of this technology in oncology research and clinical applications.

References

  1. 1.Zhang, H., Huang, Q., Shang, B., Su, G., & Tu, H. (2026). Deep learning-driven recognition of panoramic tumor microenvironment features in H&E sections and its application. Journal for Immunotherapy of Cancer. https://doi.org/10.1136/jitc-2025-014429
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service